Ultraschall Med
DOI: 10.1055/a-2487-5111
Guidelines & Recommendations

Best Practice Guidelines – DEGUM Recommendations on Breast Ultrasound

Part III/2 – Special Clinical Indications Article in several languages: English | deutsch
Claudia M. Vogel-Minea
1   Brustzentrum, Diagnostische und Interventionelle Senologie, Rottal-Inn-Kliniken Eggenfelden, Germany
,
Werner Bader
2   Zentrum für Frauenheilkunde und Geburtshilfe, Universitätsklinikum OWL der Universität Bielefeld, Campus Bielefeld, Germany
,
Jens-Uwe Blohmer
3   Gynäkologie mit Brustzentrum, Charité – Universitätsmedizin Berlin, Germany
,
Volker Duda
4   Gynäkologie, Universitätsklinikum Gießen und Marburg – Standort Marburg, Germany
,
Christian Eichler
5   Klinik für Brusterkrankungen, St.-Franziskus-Hospital Münster GmbH, Münster, Germany
,
Eva Fallenberg
6   Brustzentrum, Diagnostische und Interventionelle Senologie, Technische Universität München, Germany
,
André Farrokh
7   Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Germany
,
8   Brustzentrum Heidelberg, Klinik St.-Elisabeth Heidelberg, Germany
9   Senologie, Universitätsfrauenklinik Heidelberg, Germany
,
Ines Gruber
10   Frauenklinik, Universitätsklinikum Tübingen, Tübingen, Germany
,
Bernhard-Joachim Hackelöer
11   Mammasonografie, Praxis für pränatale Gynäkologie und Mammasonografie, Hamburg, Germany
,
Jörg Heil
12   Sektion Senologie, Universitäts-Frauenklinik Heidelberg, Germany
13   Brustzentrum Heidelberg, Klinik St.-Elisabeth Heidelberg, Germany
,
Helmut Madjar
14   Gynäkologie und Senologie, Praxis für Gynäkologie, Wiesbaden, Germany
,
Ellen Marzotko
15   Mammadiagnostik, Frauenheilkunde und Geburtshilfe, Praxis, Erfurt, Germany
,
Eberhard Merz
16   Brustultraschall, Zentrum für Ultraschall und Pränatalmedizin, Frankfurt, Germany
,
Alexander Mundinger
17   Brustzentrum Osnabrück – Bildgebende und interventionelle Mamma-Diagnostik, Franziskus-Hospital Harderberg, Niels-Stensen-Kliniken, Georgsmarienhütte, Germany
,
Markus Müller-Schimpfle
18   DKG-Brustzentrum, Klinik für Radiologie, Neuroradiologie und Nuklearmedizin Frankfurt, Frankfurt am Main, Germany
,
Ralf Ohlinger
19   Interdisziplinäres Brustzentrum, Universitätsmedizin Greifswald, Klinik für Frauenheilkunde und Geburtshilfe, Greifswald, Germany
,
Uwe Peisker
20   BrustCentrum Aachen-Kreis Heinsberg, Hermann-Josef-Krankenhaus Erkelenz, Germany
,
Ruediger Schulz-Wendtland
21   Gynäkologische Radiologie, Diagnostische Radiologie der Universität Erlangen, Germany
,
Fritz K.W. Schäfer
22   Mammazentrum, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Germany
,
Christine Solbach
23   Senologie, Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Frankfurt, Germany
,
Mathias Warm
24   Brustzentrum, Krankenhaus Holweide, Kliniken der Stadt Köln, Köln, Germany
,
Dirk Watermann
25   Frauenklinik, Evangelisches Diakoniekrankenhaus, Freiburg, Germany
,
26   Zentrum für Frauenheilkunde, Brustzentrum, Universitätsklinikum OWL, Bielefeld, Germany
,
Markus Hahn
27   Frauenklinik, Universität Tübingen, Germany
› Author Affiliations

Abstract

Breast ultrasound has been established for many years as an important method in addition to mammography for clarifying breast findings. The goal of the Best Practice Guidelines Part III of the DEGUM breast ultrasound working group is to provide colleagues working in senology with information regarding the specific medical indications for breast ultrasound in addition to the current ultrasound criteria and assessment categories published in part I and the additional and optional sonographic diagnostic methods described in part II. The value of breast ultrasound for specific indications including follow-up, evaluation of breast implants, diagnostic workup of dense breast tissue, diagnostic workup during pregnancy and lactation, and the diagnostic workup of breast findings in men is discussed. Each section after the general information section contains a description of specific pathologies, followed by a short summary and DEGUM recommendations for the particular indications. The latest S3 guidelines and AGO guidelines were taken into consideration.



Publication History

Received: 13 March 2024

Accepted after revision: 05 October 2024

Article published online:
14 January 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 
  • References

  • 1 Wojcinski S, Cassel M, Farrokh A. et al. Variations in the Elasticity of Breast Tissue During the Menstrual Cycle Determined by Real-time Sonography. J. Ultrasound Med 2012; 31 (01) 63-72
  • 2 Russo I, Medado J, Russo J. Endocrine influences on the mammary gland. In: Jones TC, Mohr U, Hunt RD. (eds) Integumenz and Mammary Glands. Berlin, Heidelberg: Springer; 1989: 252-266
  • 3 Stavros AT. Breast Anatomy: The Basis for Understanding Sonography. In Breast Ultrasound. Lippincott Williams & Wilkins; 2004: 56-108
  • 4 Ahn BY, Kim HH, Moon WK. et al. Pregnancy- and lactation-associated breast cancer: Mammographic and sonographic findings. J. Ultrasound Med 2003; 22 (05) 491-497
  • 5 Petrek JA. Breast Cancer during Pregnancy. J Natl Cancer Inst Monogr 1994; 74 (Suppl. 01) 518-527
  • 6 Smith LH, Danielsen B, Allen ME. et al. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol 2003; 189 (04) 1128-1135
  • 7 Van Calsteren K, Amant F. Cancer during pregnancy. Acta Obstet Gynecol Scand 2014; 93 (05) 443-446
  • 8 Woo JC, Yu T, Hurd TC. Breast cancer in pregnancy:a literature review. Arch Surg 2003; 138 (01) 91-98
  • 9 Nettleton J, Long J, Kuban D. et al. Breast cancer during pregnancy: quantifying the risk of treatment delay. Obstet Gynecol 1996; 87 (03) 414-418
  • 10 Samuels TH, Liu FF, Yaffe M. et al. Gestational breast cancer. Can Assoc Radiol J 1998; 49 (03) 172-180
  • 11 Wojcinski S, Stefanidou N, Hillemanns P. et al. The biology of malignant breast tumors has an impact on the presentation in ultrasound: an analysis of 315 cases. BMC Womens Health 2013; 13: 47
  • 12 Wojcinski S, Soliman AA, Schmidt J. et al. Sonographic features of triple-negative and non-triple-negative breast cancer. J. Ultrasound Med 2012; 31 (10) 1531-1541
  • 13 Pharmakovigilanz- und Beratungszentrum für Embryonaltoxikologie. Embryotox – Arzneimittelsicherheit in Schwangerschaft und Stillzeit. 2023 https://www.embryotox.de/
  • 14 Rote Liste Service GmbH. Fachinfo-Service. 2003 https://www.fachinfo.de/
  • 15 Lattin GE Jr, Jesinger RA, Mattu R. et al. From the radiologic pathology archives: diseases of the male breast: radiologic-pathologic correlation. Radiographics 2013; 33 (02) 461-489
  • 16 https://www.krebsdaten.de/Krebs/DE/Content/Publikationen/Krebs_in_Deutschland/kid_2023/kid_2023_c50_brust.pdf?__blob=publicationFile
  • 17 Niell BL, Lourenco AP, Moy L. Expert Panel on Breast Imaging. et al. ACR Appropriateness Criteria Evaluation of the Symptomatic Male Breast. J Am Coll Radiol 2018; 15 (Suppl. 11) S313-S320
  • 18 Kuhne HP, Egler S, Lenz S. et al. Gynecomastia in German Soldiers: etiology and pathology. GMS Interdiscip Plast Reconstr Surg DGPW 2012; 1: Doc03
  • 19 Gochhait D, Dehuri P, Umamahesweran S. et al. Breast Abscess Mimicking Breast Carcinoma in Male. J Midlife Health 2018; 9 (01) 39-40
  • 20 Giordano SH. A review of the diagnosis and management of male breast cancer. Oncologist 2005; 10 (07) 471-479
  • 21 Rolfes M, Borde J, Möllenhoff K. et al. Prevalence of Cancer Predisposition Germline Variants in Male Breast Cancer Patients: Results of the German Consortium for Hereditary Breast and Ovarian Cancer. Cancers (Basel) 2022; 14 (13) 3292
  • 22 Berg WA, Bandos AI, Mendelson EB. et al. Ultrasound as the Primary Screening Test for Breast Cancer: Analysis From ACRIN 6666. J Natl Cancer Inst 2015; 108 (04) djv367
  • 23 Ohuchi N, Suzuki A, Sobue T. et al. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomized controlled trial. Lancet 2016; 387: 341-348